Munar Pharma

Munar Pharma ROCE

Delisted

The Return on Capital Employed (ROCE) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is 39.74 %. In the previous year, Return on Capital Employed (ROCE) was 121.46 % — a change of -67.29% (lower).

ROCE

39.74 %

YoY

-67.29%

Last updated:

In 2024, Munar Pharma's return on capital employed (ROCE) was 39.74 %, a -67.29% increase from the 121.46 % ROCE in the previous year.

The Munar Pharma ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
-1.30 PLN
Jan 1, 2018
-580.03 PLN
Jan 1, 2019
-5.80 PLN
Jan 1, 2020
-128.28 PLN
Jan 1, 2021
-45.81 PLN
Jan 1, 2022
8.52 PLN
Jan 1, 2023
121.46 PLN
Jan 1, 2024
39.74 PLN
The Munar Pharma ROCE history
YEARROCEYoY
39.74 %-67.29%
121.46 %+1,325.92%
8.52 %-118.59%
-45.81 %-64.29%
-128.28 %+2,113.32%
-5.80 %-99.00%
-580.03 %+44,484.11%
-1.30 %-136.03%
3.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Munar Pharma's Return on Capital Employed (ROCE)

Munar Pharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Munar Pharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Munar Pharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Munar Pharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Munar Pharma stock

Return on Capital Employed (ROCE) of Munar Pharma is 39.74 % in 2024.

Return on Capital Employed (ROCE) of Munar Pharma changed from 121.46 % to 39.74 %, representing a -67.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Munar Pharma

All Key Metrics — Munar Pharma